TAMs hamper antitumoral T cell responses through several mechanisms, including inhibition of T cell proliferation, blockade of CD8 T cell migration to the tumor, and recruitment of other immunosuppressive cells such as regulatory T cells (Tregs) (8) into the TME. Here, CD8A is linked to neoplasm.